The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Cited by (1,000)

Items 401–500 of 1,000

1. Cancer's second genome: Microbial cancer diagnostics and redefining clonal evolution as a multispecies process: Humans and their tumors are not aseptic, and the multispecies nature of cancer modulates clinical care and clonal evolution
   Sepich‐Poore, Gregory D., Guccione, Caitlin, Laplane, Lucie, Pradeu, Thomas, Curtius, Kit, Knight, Rob · 2022 · BioEssays
2. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity
   Baiden-Amissah, Regina E. M., Tuyaerts, Sandra · 2019 · International Journal of Molecular Sciences
3. New therapeutic targets for cancer: the interplay between immune and metabolic checkpoints and gut microbiota
   Babita Agrawal · 2019 · Clinical and Translational Medicine
4. Emerging role of microbiota in immunomodulation and cancer immunotherapy
   Raghwendra Pratap Singh, Hilal Bashir, Rashmi Kumar · 2020 · Seminars in Cancer Biology
5. SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
   Mark Howell, Ryan J. Green, Andrew R. McGill, Rinku Dutta, Subhra Mohapatra, Shyam S. Mohapatra · 2021 · Cancers
6. Biomarkers and Future Perspectives for Hepatocellular Carcinoma Immunotherapy
   Yuqing He, Mengyao Lu, Jing Che, Qian Chu, Peng Zhang, Yuan Chen · 2021 · Frontiers in Oncology
7. In Vitro Characterisation Revealed Himalayan Dairy Kluyveromyces marxianus PCH397 as Potential Probiotic with Therapeutic Properties
   Deepika Nag, Abhishek Goel, Yogendra Shantaram Padwad, Dharam Pal Singh · 2022 · Probiotics and Antimicrobial Proteins
8. Chemoprevention effect of the Mediterranean diet on colorectal cancer: Current studies and future prospects
   Asma Ismail Mahmod, Shatha Khaled Haif, Ayah Kamal, Israa A. Al-ataby, Wamidh H. Talib · 2022 · Frontiers in Nutrition
9. Protection from chemotherapy- and antibiotic-mediated dysbiosis of the gut microbiota by a probiotic with digestive enzymes supplement
   Thomas E. Ichim, Santosh Kesari, Kim Shafer · 2018 · Oncotarget
10. Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer
    Ksenia M. Shestakova, Natalia E. Moskaleva, Andrey A. Boldin, Резванов Павел Марсельевич, Alexandr V. Shestopalov, Sergey A. Rumyantsev, E. Yu. Zlatnik, Inna Arnoldovna Novikova, A. B. Sagakyants, Софья Владимировна Тимофеева et al. · 2023 · Scientific Reports
11. Probiotic Consortia Protect the Intestine Against Radiation Injury by Improving Intestinal Epithelial Homeostasis
    Liwei Xie, Haiyan Lu, Lin-Feng Tang, Feng‐Ling Tang, Rui-Qiu Zhu, Di-Fan Wang, Shang Cai, Ye Tian, Ming Li · 2024 · International Journal of Radiation Oncology*Biology*Physics
12. Principles of Immunotherapy in Non-Small Cell Lung Cancer
    Melinda Laine Hsu, Jarushka Naidoo · 2020 · Thoracic surgery clinics/Thorac. surg. clin.
13. Impact of antibiotic treatment on immunotherapy response in women with recurrent gynecologic cancer
    Laura Chambers, Chad M. Michener, Peter Graham Rose, Ofer Reizes, Meng Yao, Roberto Vargas · 2021 · Gynecologic Oncology
14. The influence of gut microbiota in cardiovascular diseases—a brief review
    Cátia Almeida, Pedro Barata, Rúben Fernandes · 2021 · Porto Biomedical Journal
15. Association between Gut Microbiota and Development of Gestational Diabetes Mellitus
    Palin Sililas, Lingling Huang, Chanisa Thonusin, Suchaya Luewan, Nipon Chattipakorn, Siriporn Chaisin Chattipakorn, Theera Tongsong · 2021 · Microorganisms
16. Development of preclinical and clinical models for immune-related adverse events following checkpoint immunotherapy: a perspective from SITC and AACR
    Nicholas L. Bayless, Jeffrey A. Bluestone, Samantha L. Bucktrout, Lisa Helene Butterfield, Elizabeth M. Jaffee, Christian A. Koch, Bart O. Roep, Arlene H. Sharpe, William J. Murphy, Alexandra–Chloé Villani et al. · 2021 · Journal for ImmunoTherapy of Cancer
17. Human Microbiome and Its Medical Applications
    Yangming Zhang, Linguang Zhou, Jialin Xia, Ce Dong, Xiaozhou Luo · 2022 · Frontiers in Molecular Biosciences
18. The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients
    Alexander Rupert Moschen, Yossi Sammy, Zoe R. Marjenberg, Amy B. Heptinstall, Nick Pooley, Agnieszka M. Marczewska · 2022 · Current Oncology Reports
19. Lacticaseibacillus rhamnosus Probio-M9-Driven Mouse Mammary Tumor-Inhibitory Effect Is Accompanied by Modulation of Host Gut Microbiota, Immunity, and Serum Metabolome
    Weiqin Zhang, Yong Zhang, Yalin Li, Da Ma, Heping Zhang, Lai‐Yu Kwok · 2022 · Nutrients
20. Safety and effect of a low-and high-dose multi-strain probiotic supplement on microbiota in a general adult population: A randomized, double-blind, placebo-controlled study
    Tremblay, Annie, Fatani, Asmaa, Ford, Amanda L., Piano, Amanda, Nagulesapillai, Varuni, Auger, Jeremie, MacPherson, Chad W., Christman, Mary C., Tompkins, Thomas A., Dahl, Wendy J. · 2021 · Journal of Dietary Supplements
21. Emerging roles of the gut microbiota in cancer immunotherapy
    Zhuangzhuang Shi, Hongwen Li, Wenting Song, Zhi‐Yuan Zhou, Zhaoming Li, Mingzhi Zhang · 2023 · Frontiers in Immunology
22. Three-dimensional heterotypic colorectal cancer spheroid models for evaluation of drug response
    Jia Ning Nicolette Yau, Giulia Adriani · 2023 · Frontiers in Oncology
23. Advances in engineering immune–tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery
    Farnaz Dabbagh Moghaddam, Ali Anvar, Ehsan Ilkhani, Delara Dadgar, Maedeh Rafiee, Najmeh Ranjbaran, Pejman Mortazavi, Seyed Majid Ghoreishian, Yun Suk Huh, Pooyan Makvandi · 2025 · Molecular Cancer
24. Engineering bacteria for cancer therapy
    Tetsuhiro Harimoto, Tal Danino · 2019 · Emerging Topics in Life Sciences
25. Gut Microbiota Metabolite Fights Against Dietary Polysorbate 80-Aggravated Radiation Enteritis
    Yuan Li, Huiwen Xiao, Jiali Dong, Dan Luo, Haichao Wang, Shuqin Zhang, Tong Zhu, Changchun Zhu, Ming Cui, Saijun Fan · 2020 · Frontiers in Microbiology
26. Association between bacteria other than Helicobacter pylori and the risk of gastric cancer
    Madhawa Neranjan Gunathilake, Jeonghee Lee, Il Ju Choi, Young‐Il Kim, Jeongseon Kim · 2021 · Helicobacter
27. Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications
    Jianfeng Zhou, Shangwei Sun, Siyuan Luan, Xin Xiao, Yu‐Shang Yang, Chengyi Mao, Longqi Chen, Xiaoxi Zeng, Yonggang Zhang, Yong Yuan · 2021 · Frontiers in Oncology
28. Influence of Helicobacter pylori infection on PD‐1/PD‐L1 blockade therapy needs more attention
    Yanyan Shi, Huiling Zheng, Mopei Wang, Shigang Ding · 2022 · Helicobacter
29. Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients
    Shuai Jiang, Shuai Geng, Qian Chen, Chen Zhang, Mengfei Cheng, Yang Yu, Shuo Zhang, Ning Shi, Mei Dong · 2022 · Frontiers in Oncology
30. Asparagine, colorectal cancer, and the role of sex, genes, microbes, and diet: A narrative review
    Xinyi Shen, Abhishek Jain, Oladimeji B. Aladelokun, Hong Yuan Yan, Austin Gilbride, Leah M. Ferrucci, Lingeng Lu, Sajid Ali Khan, Caroline Helen Johnson · 2022 · Frontiers in Molecular Biosciences
31. The Oncobiome in Gastroenteric and Genitourinary Cancers
    Domenica Lucia D’Antonio, Simona Marchetti, Pamela Pignatelli, Adriano Piattelli, Maria Cristina Curia · 2022 · International Journal of Molecular Sciences
32. Harnessing the immune system by targeting immune checkpoints: Providing new hope for Oncotherapy
    Lu Yu, Minghan Sun, Qi Zhang, Qiao Zhou, Yi Wang · 2022 · Frontiers in Immunology
33. Impact of intestinal dysbiosis on breast cancer metastasis and progression
    Jin Zhang, Qiqi Xie, Xingfa Huo, Zhilin Liu, Mengting Da, Mingxue Yuan, Yi D. Zhao, Guoshuang Shen · 2022 · Frontiers in Oncology
34. Race, the microbiome and colorectal cancer
    Kendra J. Royston, Babatunde Adedokun, Olufunmilayo Ibironke Olopade · 2019 · World Journal of Gastrointestinal Oncology
35. Influence of microbiota on immunity and immunotherapy for gastric and esophageal cancers
    Xiaoli Zhang, Zui Pan · 2020 · Gastroenterology report
36. Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells
    Stefan Forster, Ramin Radpour · 2020 · Frontiers in Oncology
37. The Microbiome and Its Implications in Cancer Immunotherapy
    Hani Choudhry · 2021 · Molecules
38. The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis
    Karthik Rajasekaran, Ryan M. Carey, Xiang Lin, Tyler D. Seckar, Zhi Wei, Kevin T. Chorath, Jason G. Newman, Bert W. O'Malley, Gregory Steven Weinstein, Michael D. Feldman et al. · 2021 · Oral Oncology
39. Oral Microbiome Characteristics in Patients With Autoimmune Hepatitis
    Benchen Rao, Jiamin Lou, Haifeng Lu, Hongxia Liang, Juan Li, Heqi Zhou, Yajuan Fan, Hua Zhang, Ying Sun, Yawen Zou et al. · 2021 · Frontiers in Cellular and Infection Microbiology
40. Exploring the role of respiratory microbiome in lung cancer: A systematic review
    Fabiana Perrone, Lorenzo Belluomini, Marco Mazzotta, Maristella Bianconi, Vincenzo Di Noia, Fiammetta Meacci, Michele Montrone, Daniele Pignataro, Arsela Prelaj, Silvia Rinaldi et al. · 2021 · Critical Reviews in Oncology/Hematology
41. Gut microbiome, Vitamin D, ACE2 interactions are critical factors in immune-senescence and inflammaging: key for vaccine response and severity of COVID-19 infection
    Santosh Shenoy · 2021 · Inflammation Research
42. Intratumoral microbiota: new frontiers in tumor immunity
    Zhilin Zhang, Yiqun Liao, Dong Tang · 2022 · Carcinogenesis
43. Health benefits, antimicrobial activities, and potential applications of probiotics: A review
    Amin Sepehr, Seyedeh Tina Miri, Shadi Aghamohammad, Nazanin Rahimirad, Mahnaz Milani, Mohammad Reza Pourshafie, Mahdi Rohani · 2024 · Medicine
44. Microbiome within Primary Tumor Tissue from Renal Cell Carcinoma May Be Associated with PD-L1 Expression of the Venous Tumor Thrombus
    Michael Andre Liss, Yidong Chen, Ronald Rodríguez, Deepak Kumar Pruthi, Teresa L. Johnson‐Pais, Hanzhang Wang, Ahmed M. Mansour, James Robert White, Dharam Kaushik · 2020 · Advances in Urology
45. Gut Microbiota and Cancer of the Host: Colliding Interests
    György Baffy · 2020 · Advances in experimental medicine and biology
46. Bugs as drugs: The role of microbiome in cancer focusing on immunotherapeutics
    Araujo, Daniel V., Watson, Geoffrey A., Oliva, Marc, Heirali, Alya, Coburn, Bryan, Spreafico, Anna, Siu, Lillian L. · 2021 · Cancer Treatment Reviews
47. Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development
    Leliang Zheng, Jiaqi Xu, Buqing Sai, Yinghong Zhu, Lujuan Wang, Na Yin, Fenglei Yu, Wen Hu Zhou, Minghua Wu, Jingqun Tang et al. · 2020 · Frontiers in Oncology
48. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut
    Qin Yu, Christian Jobin, Ryan Michael Thomas · 2021 · Neoplasia
49. Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation
    Riccardo Masetti, Daniele Zama, Davide Leardini, Edoardo Muratore, Silvia Turroni, Patrizia Brigidi, Andrea Pession · 2021 · International Journal of Molecular Sciences
50. Microbiota‐Host Immunity Communication in Neurodegenerative Disorders: Bioengineering Challenges for In Vitro Modeling
    Lucia Boeri, Simone Perottoni, Luca Izzo, Carmen Giordano, Diego Albani · 2021 · Advanced Healthcare Materials
51. Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis
    Toshiharu Sakurai, Marco Antonio De Velasco, Kazuko Sakai, Tomoyuki Nagai, Hiroki Nishiyama, Kentaro Hashimoto, Hirotsugu Uemura, Hisato Kawakami, Kazuhiko Nakagawa, Hiroyuki Ogata et al. · 2021 · Molecular Oncology
52. Role of Biological Sex in the Cardiovascular-Gut Microbiome Axis
    Shuangyue Li, Georgios Kararigas · 2022 · Frontiers in Cardiovascular Medicine
53. Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non–small cell lung cancer
    Yu Xin, Chenguang Liu, Dan Zang, Jun Chen · 2024 · Frontiers in Immunology
54. Strategies for Predicting Response to Checkpoint Inhibitors
    Roberta Zappasodi, Jedd D. Wolchok, Taha Merghoub · 2018 · Current Hematologic Malignancy Reports
55. Proteomic analysis of microbial induced redox-dependent intestinal signaling
    Jason D. Matthews, April R. Reedy, Huixia Wu, Benjamin H. Hinrichs, Trevor M. Darby, Caroline R. Addis, Brian Scott Robinson, Young‐Mi Go, Dean P. Jones, Rheinallt M. Jones et al. · 2018 · Redox Biology
56. Live Biotherapeutic Products as Cancer Treatments
    Arianna Brevi, Amir Zarrinpar · 2023 · Cancer Research
57. Microbiota-driven interleukin-17 production provides immune protection against invasive candidiasis
    Mengmeng Li, Congya Li, Xianan Wu, Tangtian Chen, Lei Ren, Banglao Xu, Ju Cao · 2020 · Critical Care
58. The relationship between KRAS gene mutation and intestinal flora in tumor tissues of colorectal cancer patients
    Xinke Sui, Yan Chen, Baojun Liu, Lianyong Li, Xin Huang, Min Wang, Guodong Wang, Xiaopei Gao, Lu Zhang, Xinwei Bao et al. · 2020 · Annals of Translational Medicine
59. Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas
    Liting You, Juan Zhou, Zhaodan Xin, J. Spencer Hauck, Feifei Na, Jie Tang, Xiaohan Zhou, Zichen Lei, Binwu Ying · 2022 · Precision Clinical Medicine
60. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma
    Nabeel Merali, Tarak Agrebi Moumni Chouari, Kayani Kayani, Charles J. Rayner, José Ignacio Jiménez, Jonathan Krell, Elisa Giovannetti, Izhar Bagwan, Kate Relph, Timothy Rockall et al. · 2022 · Cancers
61. Cancer immunotherapy resistance: The impact of microbiome-derived short-chain fatty acids and other emerging metabolites
    Fatema Hersi, Sara M. Elgendy, Salma A. Al Shamma, Roa T. Altell, Omar Sadiek, Hany A. Omar · 2022 · Life Sciences
62. The microbiota and radiotherapy for head and neck cancer: What should clinical oncologists know?
    Miguel Reis Ferreira, Anna Pastò, Tony Ng, Vinod Patel, Teresa Guerrero Urbano, Cynthia L. Sears, William G. Wade · 2022 · Cancer Treatment Reviews
63. Therapeutic targeting of the host-microbiota-immune axis: implications for precision health
    Asiya Nazir, Fathima Hasnain Nadeem Hussain, Tuahir Hassan Nadeem Hussain, Rania Al Dweik, Afsheen Raza · 2025 · Frontiers in Immunology
64. Gut microbiota and their influence in brain cancer milieu
    Bandari BharathwajChetty, Aviral Kumar, Pranav I. Deevi, Mohamed Abbas, Athba Alqahtani, Liping Liang, Gautam Sethi, Le Liu, Ajaikumar Bahulayan Kunnumakkara · 2025 · Journal of Neuroinflammation
65. Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: a systematic review of preclinical and clinical evidence
    Csenge Somodi, Dávid Dóra, Mátyás Horváth, Gábor Szegvári, Zoltán Lohinai · 2025 · Journal of Translational Medicine
66. Preservation of the fecal samples at ambient temperature for microbiota analysis with a cost-effective and reliable stabilizer EffcGut
    Luxi Yang, Kejun Hou, Bangzhou Zhang, Cong Ouyang, Aiqiang Lin, Shuangbin Xu, Dongxian Ke, Lujing Fang, Qiongyun Chen, Jingtong Wu et al. · 2020 · The Science of The Total Environment
67. Co-infection of Malassezia sympodialis With Bacterial Pathobionts Pseudomonas aeruginosa or Staphylococcus aureus Leads to Distinct Sinonasal Inflammatory Responses in a Murine Acute Sinusitis Model
    Keehoon Lee, Irene Zhang, Shari Kyman, Oliver Kask, Emily K. Cope · 2020 · Frontiers in Cellular and Infection Microbiology
68. Sex Differences in Glioblastoma Immunotherapy Response
    Juyeun Lee, Kristen E. Kay, Katie M. Troike, Manmeet Singh Ahluwalia, Justin Durla Lathia · 2021 · NeuroMolecular Medicine
69. Significance of African Diets in Biotherapeutic Modulation of the Gut Microbiome
    Patrick Omoregie Isibor, Paul Akinniyi Akinduti, Oluwadurotimi Samuel Aworunse, JO Oyewale, Oyewumi O. Oshamika, Harriet U. Ugboko, OS Taiwo, Eze Frank Ahuekwe, Yemisi Dorcas Obafemi, Elizabeth A. Onibokun et al. · 2021 · Bioinformatics and Biology Insights
70. Nutritional Interventions Targeting Gut Microbiota during Cancer Therapies
    Emanuele Rinninella, Pauline Celine Raoul, Marco Cintoni, Marta Palombaro, Gabriele Pulcini, Antonio Gasbarrini, Maria Cristina Mele · 2021 · Microorganisms
71. Gut Microbiota: A Potential Target for Cancer Interventions
    Hu Zhou, Yuan Yuan, Haorun Wang, Wei Xiang, Shenjie Li, Haowen Zheng, Yuqi Wen, Ming Yang, Ligang Chen, Jie Zhou · 2021 · Cancer Management and Research
72. Fecal Microbiota Transplantation Effectively Cures a Patient With Severe Bleeding Immune Checkpoint Inhibitor-Associated Colitis and a Short Review
    Min-Min Chen, Mengyuan Liu, Chenyan Li, Shiqiao Peng, Yiling Li, Xiuying Xu, Mingjun Sun, Xuren Sun · 2022 · Frontiers in Oncology
73. Understanding the Potential and Risk of Bacterial Siderophores in Cancer
    Valentina Pita-Grisanti, Kaylin M. Chasser, Trevor Sobol, Zobeida Cruz‐Monserrate · 2022 · Frontiers in Oncology
74. Microbial mechanisms to improve immune checkpoint blockade responsiveness
    Matthew E. Griffin, Howard C. Hang · 2022 · Neoplasia
75. Live Biotherapeutic Lactococcus lactis GEN3013 Enhances Antitumor Efficacy of Cancer Treatment via Modulation of Cancer Progression and Immune System
    Sujeong Kim, Yunjae Kim, Suro Lee, Yulha Kim, Byungkwan Jeon, Hye‐Rim Kim, Hansoo Park · 2022 · Cancers
76. Antioxidant and Antibacterial Effects of Potential Probiotics Isolated from Korean Fermented Foods
    Anbazhagan Sathiyaseelan, Kandasamy Saravanakumar, Kiseok Han, Kumar Vishven Naveen, Myeong‐Hyeon Wang · 2022 · International Journal of Molecular Sciences
77. Updated risk factors to inform early pancreatic cancer screening and identify high risk patients
    Daniel R. Principe, Ajay Rana · 2020 · Cancer Letters
78. Microbiome Patterns in Matched Bile, Duodenal, Pancreatic Tumor Tissue, Drainage, and Stool Samples: Association with Preoperative Stenting and Postoperative Pancreatic Fistula Development
    Melanie Camilla Langheinrich, Stefan J. Wirtz, Barbara Kneis, Matthias M. Gittler, Olaf Tyc, Robert Schierwagen, Maximilian Brunner, Christian Krautz, Georg F. Weber, Christian P. Pilarsky et al. · 2020 · Journal of Clinical Medicine
79. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
    Qiang Yu, Liwei Wu, Jie Ji, Jiao Feng, Weiqi Dai, Jingjing Li, Jianye Wu, Chuanyong Guo · 2020 · Journal of Hepatocellular Carcinoma
80. Addressing Resistance to Immune Checkpoint Inhibitor Therapy: An Urgent Unmet Need
    Siwen Hu‐Lieskovan, Gabriel G. Malouf, Ira Allen Jacobs, Jeffrey Chou, Li Liu, Melissa Lynne Johnson · 2021 · Future Oncology
81. Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
    Lucia Lione, Erika Salvatori, Adriana Petrazzuolo, Alice Massacci, Roberta Maggio, Antonella Conforti, Mirco Compagnone, Luigi Aurisicchio, Gennaro Ciliberto, Fabio Palombo · 2021 · OncoImmunology
82. Recovery of human gut microbiota genomes with third-generation sequencing
    Yanfei Li, Yueling Jin, Jianming Zhang, Haoying Pan, Lan Wu, Dingsheng Liu, Jinlong Liu, Jing Hu, Junwei Shen · 2021 · Cell Death and Disease
83. Fungi, host immune response, and tumorigenesis
    Miar Elaskandrany, Rohin Patel, Mintoo M. Patel, George Miller, Deepak Saxena, Anjana D. Saxena · 2021 · American Journal of Physiology-Gastrointestinal and Liver Physiology
84. Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
    Xueting Wan, Mengyao Song, Aiyun Wang, Yang Zhao, Zhonghong Wei, Yin Lu · 2021 · Frontiers in Immunology
85. Commensal Microbiota and Cancer Immunotherapy: Harnessing Commensal Bacteria for Cancer Therapy
    Jihong Bae, Kwangcheon Park, You‐Me Kim · 2022 · Immune Network
86. The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection
    P Oster, Laurie Vaillant, Brynn McMillan, Dominique Velin · 2022 · Frontiers in Immunology
87. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment
    Anne T. Knisely, Yongwoo David Seo, Jennifer Ann Wargo, Manoj Chelvanambi · 2023 · Cancers
88. The effects of traditional Chinese medicine and dietary compounds on digestive cancer immunotherapy and gut microbiota modulation: A review
    Xiaoli Feng, Zhenhao Li, Weihong Guo, Yanfeng Hu · 2023 · Frontiers in Immunology
89. Gut Microbiome in Patients With Early-Stage and Late-Stage Melanoma
    Russell Gardner Witt, Samuel H. Cass, Tiffaney Tran, Ashish V. Damania, Emelie E Nelson, Elizabeth Sirmans, Elizabeth M. Burton, Manoj Chelvanambi, Sarah B. Johnson, Hussein A. Tawbi et al. · 2023 · JAMA Dermatology
90. The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives
    Ondřej Uher, Katerina Hadrava Vanova, David Taïeb, Bruna Calsina, Mercedes Robledo, Roderick John Clifton-Bligh, Karel Pacák · 2024 · Endocrine Reviews
91. Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study
    Francesco Schettini, Alessandra Fontana, Federica Gattazzo, Carla Strina, Manuela Milani, Maria Rosa Cappelletti, Valeria Cervoni, Lorenzo Morelli, Giuseppe Curigliano, Valerio Iebba et al. · 2023 · European Journal of Cancer
92. Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
    Elisa Monti, Clara Vianello, Ilaria Leoni, Giuseppe Galvani, Annalisa Lippolis, Federica D’Amico, Sara Roggiani, Claudio Stefanelli, Silvia Turroni, Francesca Fornari · 2025 · Cells
93. STING in cancer immunoediting: Modeling tumor-immune dynamics throughout cancer development
    Xiao Zhang, Yan Chen, Xi Liu, Genbang Li, Shuo Zhang, Qi Zhang, Zihan Cui, Minglu Qin, Hans‐Uwe Simon, Janoš Terzić et al. · 2025 · Cancer Letters
94. An interplay between human genetics and intratumoral microbiota in the progression of colorectal cancer
    Jing Yu, Yuxuan Liang, Qingrong Zhang, Hui Ding, Minghao Xie, Jingjing Zhang, Wenyan Hu, Shuguang Xu, Yiyuan Xiao, Sha Xu et al. · 2025 · Cell Host & Microbe
95. 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Tumor Response to Immunotherapy in Solid Tumors
    Rodney J. Hicks, Amir Iravani, Shahneen Kaur Sandhu · 2019 · PET Clinics
96. Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications
    Deniz Can Güven, Burak Yasin Aktaş, Cem Şimşek, Sercan Aksoy · 2020 · Future Oncology
97. Ketotherapy as an epigenetic modifier in cancer
    Borja Bandera-Merchán, Hatim Boughanem, Ana Belen Crujeiras, Manuel Macías‐González, Francisco José Tinahones · 2020 · Reviews in Endocrine and Metabolic Disorders
98. What can microfluidics do for human microbiome research?
    Hsih Yin Tan, Yi‐Chin Toh · 2020 · Biomicrofluidics
99. Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma
    Yudai Ishiyama, Tsunenori Kondo, Yuki Nemoto, Yuki Kobari, Hiroki Ishihara, Hidekazu Tachibana, Kazuhiko Yoshida, Yasunobu Hashimoto, Toshio Takagi, Junpei Iizuka et al. · 2021 · Urologic Oncology Seminars and Original Investigations
100. The Interaction Between the Microbiome and Tumors
     Yawen Zong, Yujie Zhou, Binyou Liao, Min Liao, Yangyang Shi, Wei Yu, Yu‐Yao Huang, Xuedong Zhou, Lei Cheng, Biao Ren · 2021 · Frontiers in Cellular and Infection Microbiology